2014 Q1 Form 10-Q Financial Statement
#000119312514178559 Filed on May 02, 2014
Income Statement
| Concept | 2014 Q1 | 2013 Q1 |
|---|---|---|
| Revenue | $430.5M | $430.3M |
| YoY Change | 0.04% | 2.35% |
| Cost Of Revenue | $187.7M | $174.6M |
| YoY Change | 7.53% | 4.35% |
| Gross Profit | $242.8M | $255.8M |
| YoY Change | -5.08% | 1.03% |
| Gross Profit Margin | 56.4% | 59.43% |
| Selling, General & Admin | $126.6M | $118.7M |
| YoY Change | 6.72% | 1.32% |
| % of Gross Profit | 52.16% | 46.39% |
| Research & Development | $24.75M | $25.31M |
| YoY Change | -2.24% | 8.42% |
| % of Gross Profit | 10.19% | 9.9% |
| Depreciation & Amortization | $8.819M | $8.487M |
| YoY Change | 3.91% | 9.33% |
| % of Gross Profit | 3.63% | 3.32% |
| Operating Expenses | $151.4M | $144.0M |
| YoY Change | 5.15% | 2.5% |
| Operating Profit | $88.76M | $109.4M |
| YoY Change | -18.87% | -0.74% |
| Interest Expense | $7.489M | $7.185M |
| YoY Change | 4.23% | 10.69% |
| % of Operating Profit | 8.44% | 6.57% |
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | $82.73M | $103.4M |
| YoY Change | -20.0% | -1.04% |
| Income Tax | $12.43M | -$17.65M |
| % Of Pretax Income | 15.02% | -17.07% |
| Net Earnings | $70.30M | $121.1M |
| YoY Change | -41.95% | 36.53% |
| Net Earnings / Revenue | 16.33% | 28.14% |
| Basic Earnings Per Share | $0.83 | |
| Diluted Earnings Per Share | $0.82 | $1.389M |
| COMMON SHARES | ||
| Basic Shares Outstanding | 84.98M shares | 86.05M shares |
| Diluted Shares Outstanding | 85.87M shares | 87.22M shares |
Balance Sheet
| Concept | 2014 Q1 | 2013 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $1.853B | $1.590B |
| YoY Change | 16.56% | 17.46% |
| Cash & Equivalents | $395.4M | $472.0M |
| Short-Term Investments | $1.458B | $1.118B |
| Other Short-Term Assets | $86.50M | $84.53M |
| YoY Change | 2.33% | 2.07% |
| Inventory | $266.6M | $235.9M |
| Prepaid Expenses | ||
| Receivables | $401.4M | $377.4M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $2.608B | $2.288B |
| YoY Change | 13.99% | 13.06% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $329.9M | $282.7M |
| YoY Change | 16.69% | 18.31% |
| Goodwill | $315.1M | |
| YoY Change | 1.96% | |
| Intangibles | $215.0M | |
| YoY Change | 4.69% | |
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $120.4M | $106.8M |
| YoY Change | 12.75% | 70.74% |
| Total Long-Term Assets | $1.042B | $919.6M |
| YoY Change | 13.31% | 12.71% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $2.608B | $2.288B |
| Total Long-Term Assets | $1.042B | $919.6M |
| Total Assets | $3.650B | $3.207B |
| YoY Change | 13.79% | 12.96% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $73.20M | $59.79M |
| YoY Change | 22.43% | -2.73% |
| Accrued Expenses | $39.50M | $37.00M |
| YoY Change | 6.76% | -7.5% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $232.1M | $133.2M |
| YoY Change | 74.25% | -58.84% |
| Total Short-Term Liabilities | $584.4M | $476.9M |
| YoY Change | 22.55% | -26.44% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $1.100B | $1.100B |
| YoY Change | 0.0% | 57.14% |
| Other Long-Term Liabilities | $121.3M | $29.67M |
| YoY Change | 308.83% | 0.76% |
| Total Long-Term Liabilities | $1.221B | $1.254B |
| YoY Change | -2.6% | 38.77% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $584.4M | $476.9M |
| Total Long-Term Liabilities | $1.221B | $1.254B |
| Total Liabilities | $1.830B | $1.731B |
| YoY Change | 5.75% | 11.53% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | $3.634B | |
| YoY Change | 15.73% | |
| Common Stock | $1.175B | |
| YoY Change | 5.01% | |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | $3.278B | |
| YoY Change | 11.16% | |
| Treasury Stock Shares | 68.41M shares | |
| Shareholders Equity | $1.819B | $1.477B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $3.650B | $3.207B |
| YoY Change | 13.79% | 12.96% |
Cashflow Statement
| Concept | 2014 Q1 | 2013 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $70.30M | $121.1M |
| YoY Change | -41.95% | 36.53% |
| Depreciation, Depletion And Amortization | $8.819M | $8.487M |
| YoY Change | 3.91% | 9.33% |
| Cash From Operating Activities | $115.8M | $127.8M |
| YoY Change | -9.42% | 14.93% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$21.40M | -$30.60M |
| YoY Change | -30.07% | 97.42% |
| Acquisitions | $3.615M | $0.00 |
| YoY Change | -100.0% | |
| Other Investing Activities | -$98.60M | -$59.80M |
| YoY Change | 64.88% | 26.16% |
| Cash From Investing Activities | -$119.9M | -$90.45M |
| YoY Change | 32.61% | 43.68% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $92.57M | $101.4M |
| YoY Change | -8.68% | 48.9% |
| Debt Paid & Issued, Net | $1.295M | $10.18M |
| YoY Change | -87.28% | -43.57% |
| Cash From Financing Activities | -$40.30M | -$34.58M |
| YoY Change | 16.54% | 188.3% |
| NET CHANGE | ||
| Cash From Operating Activities | $115.8M | $127.8M |
| Cash From Investing Activities | -$119.9M | -$90.45M |
| Cash From Financing Activities | -$40.30M | -$34.58M |
| Net Change In Cash | -$44.49M | $2.764M |
| YoY Change | -1709.73% | -92.37% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $115.8M | $127.8M |
| Capital Expenditures | -$21.40M | -$30.60M |
| Free Cash Flow | $137.2M | $158.4M |
| YoY Change | -13.41% | 25.02% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-28276000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-43000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
70302000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
82730000 | USD |
| CY2014Q1 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
1853000000 | USD |
| CY2013Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
1804000000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
103407000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
121059000 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
96880000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
26578000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
144000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
283000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
26717000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
|
415000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
|
516000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
142000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-2000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
|
0 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-58000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-15000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
|
-762000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-480000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
92783000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
|
931000 | USD |
| CY2013Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1187000 | USD |
| CY2013Q1 | us-gaap |
Cost Of Services
CostOfServices
|
60816000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
10053000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
1362874000 | USD |
| CY2013Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
174568000 | USD |
| CY2014Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
1457813000 | USD |
| CY2013Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
293714000 | USD |
| CY2013Q1 | us-gaap |
Interest Expense
InterestExpense
|
7185000 | USD |
| CY2013Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-17652000 | USD |
| CY2013Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
430338000 | USD |
| CY2014Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
109405000 | USD |
| CY2013Q1 | us-gaap |
Gross Profit
GrossProfit
|
255770000 | USD |
| CY2013Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
118660000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
132000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
|
762000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
-282000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-28713000 | USD |
| CY2013Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.171 | pure |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
333562000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
1.39 | |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
1.41 | |
| CY2013Q1 | wat |
Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
|
2393000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.83 | |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.82 | |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
84977000 | shares |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
85873000 | shares |
| CY2014Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.150 | pure |
| CY2013Q1 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
-2101000 | USD |
| CY2012Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
12353000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
35322000 | USD |
| CY2014Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
92572000 | USD |
| CY2014Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
8507000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-45414000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-8987000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
65632000 | USD |
| CY2013Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
10181000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
7478000 | USD |
| CY2013Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
101367000 | USD |
| CY2013Q1 | us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
30637000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-45340000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1777000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-16499000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
12840000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
506000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
6181000 | USD |
| CY2013Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
463000 | USD |
| CY2013Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1340000 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7431000 | USD |
| CY2013Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-991000 | USD |
| CY2013Q1 | us-gaap |
Depreciation
Depreciation
|
8487000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
481035000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
|
34356000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
|
26825000 | USD |
| CY2014Q1 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
410000 | USD |
| CY2014Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
11523000 | USD |
| CY2014Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1059000 | USD |
| CY2014Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1139000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8129000 | USD |
| CY2014Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-2218000 | USD |
| CY2014Q1 | us-gaap |
Depreciation
Depreciation
|
8819000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-30147000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
24163000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
8008000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
7169000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-11491000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
3330000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
115755000 | USD |
| CY2014Q1 | us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
21395000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
607028000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
512089000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-119949000 | USD |
| CY2014Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
1295000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-40299000 | USD |
| CY2014Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-921000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-34581000 | USD |
| CY2013Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-11751000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-90453000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
767541000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
127798000 | USD |
| CY2013Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
9775000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
707725000 | USD |
| CY2013Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
3163000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
3615000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
472048000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
| CY2013Q1 | us-gaap |
Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
|
-694000 | USD |
| CY2014Q1 | us-gaap |
Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
|
314000 | USD |
| CY2014Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Waters Corporation (“Waters</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">” or the “Company”) is</font><font style="font-family:Times New Roman;font-size:10pt;"> an analytical instrument manufacturer</font><font style="font-family:Times New Roman;font-size:10pt;"> that</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (“HPLC”), ultra performance liquid chromatography (“UPLC</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) </font><font style="font-family:Times New Roman;font-size:10pt;">technology </font><font style="font-family:Times New Roman;font-size:10pt;">systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that </font><font style="font-family:Times New Roman;font-size:10pt;">are frequently employed </font><font style="font-family:Times New Roman;font-size:10pt;">together</font><font style="font-family:Times New Roman;font-size:10pt;"> (“LC-MS”)</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">sold as integrated instrument systems using a common software platform</font><font style="font-family:Times New Roman;font-size:10pt;">. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease process</font><font style="font-family:Times New Roman;font-size:10pt;">es (known as “proteomics”), nutritional</font><font style="font-family:Times New Roman;font-size:10pt;"> safety analysis and environmental testing. LC</font><font style="font-family:Times New Roman;font-size:10pt;">-MS</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments </font><font style="font-family:Times New Roman;font-size:10pt;">combine </font><font style="font-family:Times New Roman;font-size:10pt;">a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. Through its TA Division (“TA</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">”), the Company primarily designs, manufactures, sells and services thermal analysis, </font><font style="font-family:Times New Roman;font-size:10pt;">rheometry</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">calorimetry</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments, which are used in predicting the suitability of fine chemicals,</font><font style="font-family:Times New Roman;font-size:10pt;"> pharmaceuticals, water,</font><font style="font-family:Times New Roman;font-size:10pt;"> polymers and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of software-based products that interface with the Company's instruments</font><font style="font-family:Times New Roman;font-size:10pt;">, as well as other manufacturers' instruments,</font><font style="font-family:Times New Roman;font-size:10pt;"> and are typically purchased by customers as part of the instrument system.</font></p> | |
| CY2014Q1 | wat |
Debt Securities
DebtSecurities
|
1422786000 | USD |
| CY2014Q1 | wat |
Derivative Notional Amount1
DerivativeNotionalAmount1
|
117000000 | USD |
| CY2013Q4 | wat |
Derivative Notional Amount1
DerivativeNotionalAmount1
|
104000000 | USD |
| CY2013Q4 | us-gaap |
Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
|
62851000 | USD |
| CY2014Q1 | us-gaap |
Foreign Currency Derivative Liabilities At Fair Value
ForeignCurrencyDerivativeLiabilitiesAtFairValue
|
410000 | USD |
| CY2014Q1 | us-gaap |
Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
|
Cash equivalents represent highly liquid investments, with original maturities of 90 days or less, while investments with longer maturities are classified as investments. | |
| CY2014Q1 | us-gaap |
Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
|
54929000 | USD |
| CY2014Q1 | wat |
Waters Restoration Plan Assets
WatersRestorationPlanAssets
|
31901000 | USD |
| CY2014Q1 | us-gaap |
Foreign Currency Derivative Assets At Fair Value
ForeignCurrencyDerivativeAssetsAtFairValue
|
370000 | USD |
| CY2014Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
1580978000 | USD |
| CY2013Q4 | wat |
Waters Restoration Plan Assets
WatersRestorationPlanAssets
|
31203000 | USD |
| CY2013Q4 | us-gaap |
Foreign Currency Derivative Assets At Fair Value
ForeignCurrencyDerivativeAssetsAtFairValue
|
929000 | USD |
| CY2013Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
1494823000 | USD |
| CY2013Q4 | us-gaap |
Foreign Currency Derivative Liabilities At Fair Value
ForeignCurrencyDerivativeLiabilitiesAtFairValue
|
88000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
88000 | USD |
| CY2014Q1 | wat |
Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-314000 | USD |
| CY2014Q1 | wat |
Unrealized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
UnrealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-881000 | USD |
| CY2014Q1 | us-gaap |
Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-1195000 | USD |
| CY2013Q1 | us-gaap |
Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
124000 | USD |
| CY2013Q1 | wat |
Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
694000 | USD |
| CY2013Q1 | wat |
Unrealized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
UnrealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-570000 | USD |
| CY2014Q1 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
1752000 | USD |
| CY2014Q1 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
-1919000 | USD |
| CY2013Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
12656000 | USD |
| CY2013Q1 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
2404000 | USD |
| CY2014Q1 | wat |
Cash Equivalents And Short Term Investments Amortized Cost Basis
CashEquivalentsAndShortTermInvestmentsAmortizedCostBasis
|
1493508000 | USD |
| CY2014Q1 | wat |
Cash Equivalents And Short Term Investments Gross Unrealized Losses
CashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses
|
-289000 | USD |
| CY2014Q1 | wat |
Cash Equivalents And Short Term Investments Gross Unrealized Gains
CashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains
|
559000 | USD |
| CY2014Q1 | wat |
Cash Equivalents And Short Term Investments Fair Value
CashEquivalentsAndShortTermInvestmentsFairValue
|
1493778000 | USD |
| CY2013Q4 | wat |
Cash Equivalents And Short Term Investments Amortized Cost Basis
CashEquivalentsAndShortTermInvestmentsAmortizedCostBasis
|
1399712000 | USD |
| CY2013Q4 | wat |
Cash Equivalents And Short Term Investments Gross Unrealized Gains
CashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains
|
371000 | USD |
| CY2013Q4 | wat |
Cash Equivalents And Short Term Investments Gross Unrealized Losses
CashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses
|
-243000 | USD |
| CY2013Q4 | wat |
Cash Equivalents And Short Term Investments Fair Value
CashEquivalentsAndShortTermInvestmentsFairValue
|
1399840000 | USD |
| CY2014Q1 | wat |
Cash Equivalents And Short Term Investments Debt Maturities Next Rolling Twelve Months Fair Value
CashEquivalentsAndShortTermInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue
|
964559000 | USD |
| CY2014Q1 | wat |
Cash Equivalents And Short Term Investments Debt Maturities Rolling Year Two Through Five Fair Value
CashEquivalentsAndShortTermInvestmentsDebtMaturitiesRollingYearTwoThroughFiveFairValue
|
458227000 | USD |
| CY2013Q4 | wat |
Cash Equivalents And Short Term Investments Debt Maturities Next Rolling Twelve Months Fair Value
CashEquivalentsAndShortTermInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue
|
1011459000 | USD |
| CY2014Q1 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
571820000 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
561485000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
322373000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P8Y | |
| CY2013 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P8Y | |
| CY2013Q4 | wat |
Cash Equivalents And Short Term Investments Debt Maturities Rolling Year Two Through Five Fair Value
CashEquivalentsAndShortTermInvestmentsDebtMaturitiesRollingYearTwoThroughFiveFairValue
|
314184000 | USD |
| CY2013Q4 | wat |
Debt Securities
DebtSecurities
|
1325643000 | USD |
| CY2014Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
88500000 | USD |
| CY2014Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
21261000 | USD |
| CY2014Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
156868000 | USD |
| CY2013Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
76930000 | USD |
| CY2013Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
19656000 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
146214000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
49000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
49000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
49000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
49000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
49000000 | USD |
| CY2014Q1 | wat |
Debt
Debt
|
1332104000 | USD |
| CY2013Q4 | wat |
Debt
Debt
|
1323346000 | USD |
| CY2013Q1 | wat |
Percentage Point Change In Effective Tax Rate Relating To Infrequent Income Tax Items
PercentagePointChangeInEffectiveTaxRateRelatingToInfrequentIncomeTaxItems
|
-32.9 | pure |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
24716000 | USD |
| CY2012Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
64390000 | USD |
| CY2014Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
23904000 | USD |
| CY2013Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
33074000 | USD |
| CY2014Q1 | wat |
Other Changes In Uncertain Tax Benefits
OtherChangesInUncertainTaxBenefits
|
-812000 | USD |
| CY2013Q1 | wat |
Other Changes In Uncertain Tax Benefits
OtherChangesInUncertainTaxBenefits
|
-805000 | USD |
| CY2014Q1 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
|
-6000000 | USD |
| CY2014Q1 | us-gaap |
Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
|
4000000 | USD |
| CY2013Q1 | wat |
Net Tax Benefit Related To Completed Tax Audit Examinations
NetTaxBenefitRelatedToCompletedTaxAuditExaminations
|
31000000 | USD |
| CY2013Q1 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
|
30511000 | USD |
| CY2014Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8129000 | USD |
| CY2013Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
7431000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
32000 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
|
0 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
32000 | shares |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
|
0 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.019 | pure |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.010 | pure |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.245 | pure |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.260 | pure |
| CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y | |
| CY2013Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
99.22 | |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
88.71 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
22.38 | |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
22.03 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3917000 | shares |
| CY2014Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
896000 | shares |
| CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
600000 | shares |
| CY2013Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1400000 | shares |
| CY2014Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
-577000 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
-21000 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3351000 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
71.08 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
88.02 | |
| CY2014Q1 | wat |
Exercise Price Range Of Options Outstanding Lower Range Limit
ExercisePriceRangeOfOptionsOutstandingLowerRangeLimit
|
37.84 | |
| CY2014Q1 | wat |
Exercise Price Range Of Options Outstanding Upper Range Limit
ExercisePriceRangeOfOptionsOutstandingUpperRangeLimit
|
103.47 | |
| CY2013Q4 | wat |
Exercise Price Range Of Options Outstanding Lower Range Limit
ExercisePriceRangeOfOptionsOutstandingLowerRangeLimit
|
33.12 | |
| CY2013Q4 | wat |
Exercise Price Range Of Options Outstanding Upper Range Limit
ExercisePriceRangeOfOptionsOutstandingUpperRangeLimit
|
103.47 | |
| CY2014Q1 | wat |
Exercise Price Range Of Options Exercised Lower Range Limit
ExercisePriceRangeOfOptionsExercisedLowerRangeLimit
|
33.12 | |
| CY2014Q1 | wat |
Exercise Price Range Of Options Exercised Upper Range Limit
ExercisePriceRangeOfOptionsExercisedUpperRangeLimit
|
87.06 | |
| CY2014Q1 | wat |
Exercise Price Range Of Options Canceled Upper Range Limit
ExercisePriceRangeOfOptionsCanceledUpperRangeLimit
|
98.21 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
59.77 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
73.19 | |
| CY2014Q1 | wat |
Exercise Price Range Of Options Canceled Lower Range Limit
ExercisePriceRangeOfOptionsCanceledLowerRangeLimit
|
79.15 | |
| CY2013Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1166000 | shares |
| CY2014Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | pure |
| CY2014Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | pure |
